tiprankstipranks
Trending News
More News >

John M. Dineen Insider Profile

4 Followers
John M. Dineen, Director at Merrimack Pharmaceuticals, holds 7.50K shares in Lam Research (Ticker: LRCX), holds 1.83K shares in Cognizant (Ticker: CTSH), holds 0.00 shares in Syneos Health (Ticker: SYNH).
tipranks
John M. Dineen

John M. Dineen
Merrimack Pharmaceuticals (MACK)
Director

Not Ranked
John M. Dineen has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$745K
79.58%
20.42%
A breakdown of John M. Dineen's holdings

Insider Roles

Lam Research
(LRCX)
Director
Cognizant
(CTSH)
Director
Roles that John M. Dineen holds in companies

Most Profitable Insider Trade

Stock:
Merrimack Pharmaceuticals
(MACK)
Rating:Informative Buy
Date:Aug 13, 2015 - Aug 13, 2016
Return:-51.00%
The most profitable trade made by John M. Dineen

John M. Dineen's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
MACK
Merrimack Pharmaceuticals
Aug 13, 2015
Informative Buy
1.01M
$1.51M
Cognizant
Nov 15, 2023
Director
Uninformative Buy
108.74K
$152.06K
SYNH
Syneos Health
Sep 28, 2023
Uninformative Sell
973.05K
$0.00
Lam Research
Nov 12, 2024
Director
Uninformative Buy
$592.58K
List of latest transactions for each holding click on a transaction to see John M. Dineen's performance on stock

John M. Dineen insider profile FAQ

What is the percentage of profitable transactions made by John M. Dineen?
The percentage of profitable transactions made by John M. Dineen is ―.
    What is the average return per transaction made by John M. Dineen?
    The average return per transaction made by John M. Dineen is ―.
      What stocks does John M. Dineen hold?
      John M. Dineen holds: MACK, CTSH, SYNH, LRCX stocks.
        What was John M. Dineen’s latest transaction?
        John M. Dineen latest transaction was an Uninformative Buy of ―.
          What was John M. Dineen's most profitable transaction?
          John M. Dineen’s most profitable transaction was an Informative Buy of MACK stock on August 13, 2015. The return on the trade was -51.00%.
            What is John M. Dineen's role in Merrimack Pharmaceuticals?
            John M. Dineen's role in Merrimack Pharmaceuticals is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.